ARCHIVES

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

This article is from The Cancer Letter archive.

Vol. 40 No. 05 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds

May 10, 1974

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991